Have a personal or library account? Click to login
Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation Cover

Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation

Tremor and Other Hyperkinetic Movements
Volume 9 (2019): Issue 0
By: Nester Mitchell,  Gaynel A. LaTouche,  Beverly Nelson,  Karla P. Figueroa,  Ruth H. Walker and  Andrew K. Sobering  
Open Access
|Sep 2019

References

  1. 1WallaceSE, BirdTD Molecular genetic testing for hereditary ataxia. Neurol Clin Pract 2018;8(1):27–32. doi: 10.1212/CPJ.000000000000042129517052
    Back to article
  2. 2SunYM, LuC, WuZY Spinocerebellar ataxia: relationship between phenotype and genotype – a review. Clin Genet 2016;90(4):305–14. doi: 10.1111/cge.1280827220866
    Back to article
  3. 3MundwilerA, ShakkottaiVG Autosomal-dominant cerebellar ataxias. In: GeschwindDH, PaulsonHL, KleinC, editors. Handbook of clinical neurology (vol. 147). Amsterdam: Elsevier B.V.; 2018 (2nd edition), pp. 173–185.
    Back to article
  4. 4DongY, SunYM, NiW, GanSR, WuZY Chinese patients with spinocerebellar ataxia type 3 presenting with rare clinical symptoms. J Neurol Sci 2013;324:167–71. doi: 10.1016/j.jns.2012.10.03023174085
    Back to article
  5. 5GiuntiP, SweenyMG, HardingAE Detection of the Machado-Joseph disease/spinocerebellar ataxia three nucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walwort. Brain 1995;118:1077–85. doi: 10.1093/brain/118.5.10777496771
    Back to article
  6. 6KawaguchiY, OkamotoT, TaniwakiM, AizawaM, InoueM, KatayamaS, et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet 1994;8(3):221–8. doi: 10.1038/ng1194-2217874163
    Back to article
  7. 7SchölsL, Vieira-saeckerAMM, SchölsS, PrzuntekH, EpplenJT, RiessO Trinucleotide expansion within the MJD1 gene presents clinically as spinocerebellar ataxia and occurs most frequently in german SCA patients. Hum Mol Genet 1995;4(6):1001–5. doi: 10.1093/hmg/4.6.10017655453
    Back to article
  8. 8du MontcelST, DurrA, RakowiczM, NanettiL, CharlesP, SulekA, et al. Prediction of the age at onset in spinocerebellar ataxia type 1, 2, 3 and 6. J Med Genet 2014;51(7):479–86. doi: 10.1136/jmedgenet-2013-10220024780882
    Back to article
  9. 9JacobiH, du MontcelST, BauerP, GiuntiP, CookA, LabrumR, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol 2015;14(11):1101–8. doi: 10.1016/S1474-4422(15)00202-126377379
    Back to article
  10. 10ZhouYX, TakiyamaY, IgarashiS, LiYF, ZhouBY, GuiDC, et al. Machado-Joseph disease in four Chinese pedigrees: molecular analysis of 15 patients including two juvenile cases and clinical correlations. Neurology 1997;48:482–5. doi: 10.1212/WNL.48.2.4829040742
    Back to article
  11. 11DonisKC, SauteAJM, Krum-santosAC, FurtadoGV, MattosEP, Saraiva-PereiraML, et al. Spinocerebellar ataxia type 3/Machado-Joseph disease starting before adolescence. Neurogenetics 2016;17:107–13. doi: 10.1007/s10048-016-0473-526780339
    Back to article
  12. 12CarvalhoDR, La Rocque-FerreiraA, RizzoIM, ImamuraEU, Speck-MartinsCE Homozygosity enhances severity in spinocerebellar ataxia type 3. Pediatr Neurol 2008;38(4):296–9. doi: 10.1016/j.pediatrneurol.2007.12.00618358414
    Back to article
  13. 13ZengS, ZengJ, HeM, ZengX, ZhouY, LiuZ, et al. Chinese homozygous Machado-Joseph disease (MJD)/SCA3: a case report. J Hum Genet 2015;60:157–60. doi: 10.1038/jhg.2014.11725566755
    Back to article
  14. 14Bettencourt, Conceiccao RaposoM, KazachkovaN, CymbronT, SantosC, KayT, VasconcelosJ, et al. The APOE E2 allele increases the risk of earlier age at onset in Machado-Joseph disease. Arch Neurol 2011;68(12):1580–3. doi: 10.1001/archneurol.2011.63622159055
    Back to article
  15. 15ChenS, GanS, CaiP-P, NiW, ZhouQ, DongY, et al. Mitochondrial NADH Dehydrogenase subunit 3 polymorphism associated with an earlier age at onset in male Machado-Joseph disease patients. CNS Neurosci Ther 2016;22:38–42. doi: 10.1111/cns.1244326336829
    Back to article
  16. 16ZhouQ, NiW, DongY, WangN, GanS-R, WuZ-Y The role of apolipoprotein E as a risk factor for an earlier age at onset for Machado-Joseph disease is doubtful. PLoS One 2014;9(11):9–12. doi: 10.1371/journal.pone.0111356
    Back to article
  17. 17De MattosEP, Kolbe MusskopfM, Bielefeldt LeottiV, Saraiva-PereiraML, JardimLB Genetic risk factors for modulation of age at onset in Machado-Joseph disease/spinocerebellar ataxia type 3: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2019;90(2):203–10. doi: 10.1136/jnnp-2018-31920030337442
    Back to article
  18. 18du MontcelST, DurrA, BauerP, FigueroaKP, IchikawaY, BrussinoA, et al. Modulation of the age at onset in spinocerebellar ataxia by CAG tracts in various genes. Brain 2014;137(9):2444–55. doi: 10.1093/brain/awu17424972706
    Back to article
  19. 19PaulsonH Machado-Joseph disease/spinocerebellar ataxia type 3. Handb Clin Neurol 2012;103:437–49. doi: 10.1016/B978-0-444-51892-7.00027-921827905
    Back to article
  20. 20NunesMB, MartinezARM, RezendeTJR, FriedmanJH, Lopes-CendesI, D’AbreuA, et al. Dystonia in Machado-Joseph disease: clinical profile, therapy and anatomical basis. Park Relat Disord 2015;21(12):1441–7. doi: 10.1016/j.parkreldis.2015.10.016
    Back to article
  21. 21CataiLMP, CamargoCHF, MoroA, RibasG, RaskinS, TeiveHAG Dystonia in patients with spinocerebellar ataxia 3 – Machado-Joseph disease: an underestimated diagnosis? Open Neurol J 2018;12:41–9. doi: 10.2174/1874205X0181201004130008965
    Back to article
  22. 22MoroA, MunhozRP, MoscovichM, ArrudaWO, RaskinS, TeiveHAG Movement disorders in spinocerebellar ataxias in a cohort of brazilian patients. Eur Neurol 2014;72(5–6):360–2. doi: 10.1159/00036528525322786
    Back to article
  23. 23RaoofiS, KhorshidiH, NajafiM Etiology, Diagnosis and management of oromandibular dystonia: an update for stomatologists. J Dent Shiraz Univ Med Sci 2017;18(2):73–81.
    Back to article
  24. 24TermsarasabP, TanenbaumDR, FruchtSJ The phenomenology and natural history of idiopathic lower cranial dystonia. J Clin Mov Disord 2014;1(3):1–10. doi: 10.1186/2054-7072-1-326788327
    Back to article
  25. 25SchneiderSA, AggarwalA, BhattM, DupontE, TischS, LimousinP, et al. Severe tongue protrusion dystonia clinical syndromes and possible treatment. Neurology 2006;67:940–3. doi: 10.1212/01.wnl.0000237446.06971.7217000958
    Back to article
  26. 26AshizawaT, FigueroaKP, PerlmanSL, GomezCM, WilmotGR, SchmahmannJD, et al. Clinical characteristics of spinocerebellar ataxias 1, 2, 3 and 6 in the US; a prospective observational study. Orphanet J Rare Dis 2013;8:1–8. doi: 10.1186/1750-1172-8-17723286897
    Back to article
  27. 27MoscovichM, OkunMS, FavillaC, FigueroaKP, PulstSM, PerlmanS, et al. Clinical evaluation of eye movements in spinocerebellar ataxias: a prospective multicenter study. J Neuro-Ophthalmology 2015;35(1):1–11. doi: 10.1097/WNO.0000000000000167
    Back to article
  28. 28GantenbeinAR, Damon-PerriereN, BohlenderJE, ChauveauM, LatxagueC, MirandaM, et al. Feeding dystonia in McLeod syndrome. Mov Disord 2011;26(11):2123–6. doi: 10.1002/mds.2384321714011
    Back to article
  29. 29GonzálezCA, DíazAV, RiescoDF, ChávezMH Oral self-mutilation in Lesch-Nyhan syndrome. Case report. Rev Chil Pediatr 2018;89(1):86–90. doi: 10.4067/S0370-4106201800010008629664508
    Back to article
  30. 30KumarTS, MosesPD Isolated tongue involvement-An unusual presentation of Wilson’s disease. J Postgr Med 2005;51:337.
    Back to article
  31. 31BrissaudO, ThébaudN-B, GuichouxJ, SmiraniR, VillegaF, DevillardR Case report of a severe recurrent tongue self-injury in an infant with dystonia. Pediatrics 2016;138(5):e20160738. doi: 10.1542/peds.2016-0738
    Back to article
  32. 32JinnahHA, NeychevV, HessEJ The anatomical basis for dystonia: the motor network model. Tremor Other Hyperkinet Mov (N Y) 2017;7:506.29123945
    Back to article
  33. 33PaucarM, LindestadP-Å, WalkerRH, SvenningssonP Teaching video neuro images: feeding dystonia in chorea-acanthocytosis . Neurology 2015;85(19):e143–4. doi: 10.1212/WNL.000000000000210826553947
    Back to article
  34. 34YoshidaK Botulinum neurotoxin therapy for lingual dystonia using an individualized injection method based on clinical features. Toxins (Basel) 2019;11(51):1–18. doi: 10.3390/toxins11010051
    Back to article
  35. 35CharlesJ, LesseyL, RooneyJ, ProkopI, YearwoodK, Da BreoH, et al. Presentation and care of a family with Huntington disease in a resource-limited community. J Clin Mov Disord 2017;4:1–8. doi: 10.1186/s40734-017-0050-628101372
    Back to article
  36. 36YearwoodAK, RethiS, FigueroaKP, WalkerRH, SoberingAK Diagnosis of spinocerebellar ataxia in the West Indies. Tremor Other Hyperkinet Mov 2018;1–5. doi: 10.7916/D8DV329C
    Back to article
DOI: https://doi.org/10.5334/tohm.484 | Journal eISSN: 2160-8288
Journal RSS Feed
Language: English
Submitted on: Jun 12, 2019
Accepted on: Aug 12, 2019
Published on: Sep 13, 2019
Published by: Columbia University Libraries/Information Services
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
Spinocerebellar ataxia type 3,
childhood onset,
tongue dystonia,
lingual dystonia,
polyglutamine tract expansion disorder

© 2019 Nester Mitchell, Gaynel A. LaTouche, Beverly Nelson, Karla P. Figueroa, Ruth H. Walker, Andrew K. Sobering, published by Columbia University Libraries/Information Services
This work is licensed under the Creative Commons License.

Previous articleVolume 9 (2019): Issue 0Next article